Market Place
Sourcing Support
Genzyme`s Wayrilz Receives Approval in US
29 Aug 2025 //
FDA
Sanofi`s Avapro Receives Approval in US
01 Aug 2025 //
FDA
Sanofi-Aventis`s Tzield Receives Approval in Canada
05 May 2025 //
HEALTH CANADA
Sanofi`s Altuviiio Receives Approval in Canada
26 Mar 2025 //
HEALTH CANADA
Sanofi`s Biologic Merilog Solostar Receives Approval in US
14 Feb 2025 //
FDA
Sanofi`s Biologic Merilog Receives Approval in US
14 Feb 2025 //
FDA
Genzyme`s Biologic Lumizyme Receives Suppl Approval in US
30 Dec 2024 //
FDA
Genzyme`s Biologic Cerezyme Receives Suppl Approval in US
19 Dec 2024 //
FDA
Sanofi`s Biologic Soliqua Receives Suppl Approval in US
01 Nov 2024 //
FDA
Sanofi`s Biologic Sarclisa Receives Suppl Approval in US
25 Oct 2024 //
FDA
Sanofi `s Biologic Sarclisa (Isatuximad) Receives Suppl Approval in US
20 Sep 2024 //
FDA
Genzyme `s Biologic Cerezyme (Imiglucerase ) Receives Suppl Approvals in US
10 Jul 2024 //
FDA
Sanofi Synthelabo Biologic Sarilumab Receives Approval in US
10 Jun 2024 //
FDA
Genzyme`s Campath (alemtuzumab) Receives Suppl Approval in the U.S.
20 May 2024 //
FDA
Genzyme`s Lemtrada (alemtuzumab) Receives Suppl Approval in the U.S.
20 May 2024 //
FDA
Ablynx NV`s Cablivi (caplacizumab) Receives Suppl Approval in the U.S.
11 Apr 2024 //
FDA
Bioverativ`s Biologic Enjaymo (sutimlimab) Receives Approval in the U.S.
09 Feb 2024 //
FDA
Genzyme`s Biologic Campath (alemtuzumab) Receives Approval in the U.S.
08 Feb 2024 //
FDA
Sanofi`s Biologic Zaltrap (ziv-aflibercept) Receives Approval in the U.S.
13 Dec 2023 //
FDA
Sanofi`s Biologic Sarclisa (isatuximab) Receives Approval in the U.S.
01 Nov 2023 //
FDA
Sanofi`s Truvelog Mix 30 (insulin aspart) Approved In Europe
06 Jul 2023 //
EMA
Sanofi`s Biologic APIDRA (Insulin Glulisine) Receives Approval in the U.S.
30 Nov 2022 //
FDA
Provention`s Biologic Tzield (Teplizumab) Receives Approval in the U.S.
17 Nov 2022 //
FDA
Sanofi`s Sarclisa (isatuximab IRFC) Receives Supplemental Approval in U.S.
15 Jul 2022 //
FDA
Sanofi Aventis Adlyxin (Lixisenatide) Receives Approval in the U.S.
10 Jun 2022 //
FDA
Genzyme`s Lemtrada (alemtuzumab) Receives Approval in the U.S.
26 May 2022 //
FDA
Genzyme`s Lumizyme(alglucosidase alfa) Receives Approval in the U.S.
12 May 2022 //
FDA
Genzyme`s Biologic Lemtrada (Alemtuzumab) Receives Approval in the U.S.
13 Jan 2022 //
FDA
Genzyme`s Biologic Campath (Alemtuzumab) Receives Approval in the U.S.
13 Jan 2022 //
FDA
Genzyme`s Biologic Cerezyme (Imiglucerase) Receives Approval in the U.S.
22 Dec 2021 //
FDA
Genzyme`s Biological Alemtuzumab Receives Approval In the US
20 Aug 2021 //
FDA
Sanofi Aventis Sarclisa (isatuximab)Receives Supplemental Approval in US
24 Mar 2021 //
FDA
Sanofi`s Biological Isatuximab-Irfc Receives Approval In US
19 Mar 2021 //
FDA
Genzyme`s Campath (Alemtuzumab) Receives Supplimental Approval in US
27 Oct 2020 //
FDA
Genzyme`s Lemtrada (Alemtuzumab) Receives Supplimental Approval in US
27 Oct 2020 //
FDA
Sanofi`s Insulin aspart Sanofi (insulin aspart) Receives Approval in Europe
07 Jul 2020 //
EMA
Sanofi Aventis Praluent (Alirocumab ) Receives Supplemental Approval in US
12 Mar 2020 //
FDA
Genzyme`s Myozyme (Alglucosidase alfa) Receives Supplimental Approval in U.S
20 Feb 2020 //
FDA
Genzyme`s CAMPATH (Alemtuzumab) Receives Supplimental Approval in U.S
27 Nov 2019 //
FDA
Genzyme`s LEMTRADA (Alemtuzumab) Receives Supplimental Approval in U.S
27 Nov 2019 //
FDA
Sanofi`s ZALTRAP (Ziv-aflibercept) Receives Supplimental Approval in U.S
26 Nov 2019 //
FDA
Genzyme`s Fabrazyme (Agalsidase Beta) Receives Supplemental Approval in US
05 Nov 2019 //
FDA
Genzyme’s Lemtrada (Alemtuzumab) Receives Supplemental Approval In US
29 Oct 2019 //
FDA
Genzyme’s Campath (Alemtuzumab) Receives Supplemental Approval In US
29 Oct 2019 //
FDA
Kadmon Pharma`s Generic Trientine Hydrochloride Receives Approval in US
23 Oct 2019 //
FDA
Genzyme’s Campath (Alemtuzumab) Receives Supplemental Approval In US
03 Aug 2019 //
FDA
Sanofi Aventis Praluent (Alirocumab) Receives Supplemental Approval in US
30 Apr 2019 //
FDA
Genzyme`s Campath (Alemtuzumab) Receives Approval in US
25 Apr 2019 //
FDA
